Authors: Prasher, JM Elenitoba-Johnson, KSJ Kelley, LL

Citation: Jm. Prasher et al., Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia, ONCOGENE, 20(23), 2001, pp. 2946-2955

Authors: Hsieh, FF Bamett, LA Green, WF Freedman, K Matushansky, I Skoultchi, AI Kelley, LL

Citation: Ff. Hsieh et al., Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase, BLOOD, 96(8), 2000, pp. 2646-2654

Authors: Hsieh, FF Barnett, LA Green, WF Freedman, K Matushansky, I Skoultchi, AI Kelley, LL

Citation: Ff. Hsieh et al., Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase, BLOOD, 96(8), 2000, pp. 2746-2754

Authors: Bills, AC Green, WF Tsodikov, A Carey, MJ Perkins, SL Petersen, FB Beatty, PG Kelley, LL

Citation: Ac. Bills et al., Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumors, CYTOTHERAPY, 1(5), 1999, pp. 389-399